Sangamo Therapeutics Overview
Sangamo Therapeutics Discounted Cash Flow
DCF Analysis for SGMO.
Get informed when a big investor buys or sells
+ FollowFair Value
$2.35
Current Fair Value
$2.35
↑ 1322.6% Upside
Undervalued by 1322.6% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison